Cytarabine manufacturer

Cytarabine

147-94-4
Product Name: Cytarabine
Product Code: HWSWATBG
Specification: 99%
Certifications:ISO,GMP
Product grade:USP
Delivery:Shipped on the same day from stocks
MOQ:1KG
Product Name
Cytarabine
Appearance
White powder 
Specification
99%
Test Method
HPLC
Storage
Keep in a cool, dry, dark location in a tightly sealed container or cylinder.
Shelf Time
24 months 
     
Xi'an Huawave Biotech Co., Ltd. is a professional Cytarabine manufacturer and Cytarabine supplier . We are committed to providing customers with professional research and development, production and sales, as well as OEM and ODM processing services.
Cytarabine is an important chemotherapy drug with diverse mechanisms of action, as follows:
1、 Antitumor effect
The main function of cytarabine is to inhibit the growth and division of cancer cells by interfering with the DNA synthesis process of cells. It can competitively inhibit guanine nucleotide dehydrogenase, hinder the conversion of deoxyadenosine monophosphate to deoxyguanosine monophosphate, and thus block DNA synthesis. In addition, cytarabine can also serve as a substrate for DNA polymerase and participate in the process of DNA synthesis. However, due to its molecular structure similar to natural bases, it can be incorporated into newly synthesized DNA strands by pairing with complementary bases on the DNA template strand, leading to DNA replication errors and inducing apoptosis of tumor cells. This mechanism of action makes cytarabine perform well in combating diseases such as acute leukemia and myelodysplastic syndrome.
2、 Immune regulatory function
Cytarabine can affect the function and proliferation of T lymphocytes, thereby reducing the body's immune response. This characteristic is particularly important in preventing rejection reactions after organ transplantation, and also has a certain therapeutic effect on certain autoimmune diseases.
3、 Improve hematopoietic function
Cytarabine can also stimulate the proliferation and differentiation of hematopoietic stem cells, increase the number of red blood cells, white blood cells, and platelets in the blood, and help improve blood diseases such as anemia.
4、 Enhance chemotherapy sensitivity
Cytarabine can increase the sensitivity of tumor cells to other chemotherapy drugs, allowing chemotherapy drugs to work better. This effect is particularly important for leukemia patients with strong drug resistance. When cytarabine is used in combination with other chemotherapy drugs, it can enhance chemotherapy efficacy and improve treatment efficiency.
5、 Other functions
In addition to the above functions, cytarabine can also inhibit the replication of viral RNA by interfering with the transcription process of RNA, thus playing a certain role in the treatment of viral infectious diseases. In addition, it is also used to treat diseases such as cerebellar granule cell tumors.
6、 Clinical application
Cytarabine is mainly used in clinical practice for inducing remission and maintenance therapy of acute non lymphocytic leukemia in adults and children, and also has therapeutic effects on types of leukemia such as acute lymphocytic leukemia and chronic myeloid leukemia. In addition, it has certain therapeutic effects on solid tumors such as malignant lymphoma, lung cancer, digestive tract cancer, head and neck cancer, and viral infectious diseases such as viral keratitis and epidemic conjunctivitis.
7、 Medication precautions
The use of cytarabine requires doctors to develop personalized treatment plans based on the patient's specific condition and severity of the illness.
During use, it is necessary to closely monitor changes in the patient's hematological parameters, such as the number of white blood cells, granulocytes, platelets, as well as indicators of liver and kidney function, to prevent drug induced side effects.
Cytarabine may cause adverse reactions such as bone marrow suppression, nausea and vomiting, dizziness, insomnia, and skin lesions. If patients experience severe discomfort, they should seek medical treatment promptly.
Pregnant women should not use this product to avoid affecting fetal health.
In summary, cytarabine is a chemotherapy drug with multiple mechanisms of action and has broad clinical application value. However, it is necessary to pay attention to the possible side effects and adverse reactions during use, and use it reasonably under the guidance of a doctor.
The application scope of cytarabine is relatively wide, mainly reflected in the following aspects:
1、 Anti tumor application
Leukemia treatment
Cytarabine is an important drug for the treatment of acute leukemia (including acute lymphocytic leukemia and non lymphocytic leukemia), suitable for inducing remission, maintaining consolidation, and the acute phase of chronic myeloid leukemia.
It exerts anti-tumor effects by inhibiting the synthesis of cellular DNA and interfering with cell proliferation.
Lymphoma treatment
Cytarabine is also used for the treatment of malignant lymphoma, usually in combination with other chemotherapy drugs.
Other solid tumors
Cytarabine has also shown certain therapeutic effects on solid tumors such as lung cancer, digestive tract cancer, and head and neck cancer.
2、 Antiviral applications
Eye virus infection
Cytarabine can be used to treat ocular viral infections such as viral keratitis and epidemic keratitis.
Other viral infections
Some studies have shown that cytarabine can also inhibit herpes, varicella, herpes zoster virus, and can be used to treat related viral infectious diseases, such as herpetic encephalitis.
3、 Immune regulation and improvement of hematopoietic function
Immune regulation
Cytarabine can affect the function and proliferation of T lymphocytes, thereby reducing the body's immune response, which is particularly important in preventing rejection reactions after organ transplantation.
Improvement of hematopoietic function
By stimulating the proliferation and differentiation of hematopoietic stem cells, cytarabine can increase the number of red blood cells, white blood cells, and platelets in the blood, which can help improve blood diseases such as anemia.
4、 Medication methods and precautions
Medication method
Cytarabine is not suitable for oral administration because its oral absorption is small and it is easily inactivated by the dehydrogenation of cytosine ribonucleic acid in the gastrointestinal mucosa and liver. Therefore, it is usually administered by intravenous, subcutaneous, intramuscular, or intrathecal injection.
matters needing attention
Cytarabine is a bone marrow inhibitor that may cause bone marrow suppression in patients, manifested as a decrease in white blood cells, granulocytes, and platelets. Therefore, close monitoring of blood count is required during use.
Cytarabine may also cause certain damage to the liver or kidneys of patients, so close monitoring of liver and kidney function is also necessary.
Pregnant and lactating women are prohibited from using this product to avoid affecting the health of the fetus or infant.
During use, patients may experience bone pain, muscle pain, sore throat, fever, general discomfort, as well as adverse reactions such as rash and red eyes. If the symptoms are severe or persist, seek medical attention promptly.
In summary, cytarabine has broad application value in anti-tumor, antiviral, immune regulation, and hematopoietic function improvement. However, it is necessary to pay attention to the possible side effects and adverse reactions during use, and use it reasonably under the guidance of a doctor.